ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
63,508.09
0.15%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kineta Inc (KA)

  7. Kineta Inc (KA) News

Kineta Inc

Kineta Inc (KA)

NASDAQ
0.61
-0.0298
(-4.66%)
Closed April 28 4:00PM
Delayed by 15 minutes
0.5902
-0.0198
(-3.25%)
After Hours: 4:37PM
Delayed by 15 minutes

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

KA News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
February 29 2024
KA (-4.66%)

Form 8-K - Current report
Edgar (US Regulatory)
January 17 2024
KA (-4.66%)

Form 8-K - Current report
Edgar (US Regulatory)
January 05 2024
KA (-4.66%)

Form 8-K - Current report
Edgar (US Regulatory)
December 15 2023
KA (-4.66%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 06 2023
KA (-4.66%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 30 2023
KA (-4.66%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
November 13 2023
KA (-4.66%)

Form 8-K - Current report
Edgar (US Regulatory)
November 06 2023
KA (-4.66%)

KA Discussion

View Posts
INV4 INV4 6 days ago
Thanks Gail!

HOD 0.74 so far today 😃

$KA
👍️0
gail gail 1 week ago
its up 17% so ……

….

far today it shows, so im happy for you.
👍️ 1
INV4 INV4 1 week ago
Ok lol 😄 Well I like the Float (6.59M) / OS (10.96M).

(I've seen such an $8 price target with $OCEA when it was trading at $0.50 cents or something and it hit $7.79. I took a small starter here... Whatever happens, it's all good).

KINETA INC (KA):
Shares Outstanding 10.96M
Shares Change (YoY) +124.40%
Shares Change (QoQ) +8.20%
Owned by Insiders (%) 29.25%
Owned by Institutions (%) 12.05%
Float 6.59M

GLTY

$KA
👍️0
gail gail 1 week ago
moved on to bigger and better things, lol
👍️0
INV4 INV4 1 week ago
Have you seen this price target? I don't know if that target is realistic/achievable here?

================

Kineta (KA) Price Target Increased by 25.58% to 13.77
April 17, 2024 — 08:19 pm EDT

The average one-year price target for Kineta (NasdaqCM:KA) has been revised to 13.77 / share. This is an increase of 25.58% from the prior estimate of 10.96 dated March 28, 2024.

The price target is an average of many targets provided by analysts. The latest targets range from a low of 13.64 to a high of 14.18 / share. The average price target represents an increase of 2,770.54% from the latest reported closing price of 0.48 / share.

https://www.nasdaq.com/articles/kineta-ka-price-target-increased-by-25.58-to-13.77

$KA
👍️0
gail gail 2 weeks ago
in a good way? i see we are moving up now.
👍️0
Awl416 Awl416 2 weeks ago
Watch out
👍️0
Awl416 Awl416 3 weeks ago
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
👍️0
Monksdream Monksdream 2 months ago
KA new 52 week lo
👍️0
AJ Freely AJ Freely 9 months ago
$KA - Up 7% Pre-Market/ Current Price $2.48
To Receive $5 Million Milestone Payment from Merck & eligible to receive additional milestone payments totaling up to $255m associated with the successful development of marketed products for pipeline program | 6/20.23
👍️0
makinezmoney makinezmoney 1 year ago
$KA : Here you go............


https://investorshub.advfn.com/Starry-GROUP-Holdings-41712

Merr Christmas



GO $KA
👍️0
tw0122 tw0122 1 year ago
Can you get them to open up comments on STRY you have clout.. Lol up over 1,436 percent biggest runner today..

Starry got delisted
👍️0
makinezmoney makinezmoney 1 year ago
$KA: ReverseMerger with Yumanity Thera completed


https://kinetabio.com/

Added 10k here at $4.50 !!!!!!!!!!


LETS GOOooooooooooooooooooooooooooooooooo


The Company
Kineta is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy. Kineta’s focus on innate immunity differentiates it from other immuno-oncology companies that are primarily focused on adaptive immunity and T cell focused therapies.
Kineta has established its immuno-oncology focused platform aimed at developing fully human antibodies to address the major mechanisms of cancer immune resistance. With drug candidates expected to enter the clinic and additional immuno-oncology assets in preclinical development, Kineta believes it is positioned to achieve multiple value-driving catalysts.

Kineta has assembled an experienced management team, a seasoned research and development team, an immuno-oncology focused scientific advisory board, an enabling technology platform and a leading intellectual property position to advance its pipeline of potential novel immunotherapies for cancer patients.


GO $KA
👍️0

Your Recent History

NASDAQ
KA
Kineta
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved